![Heather A. Ellerkamp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Heather A. Ellerkamp
Keine laufenden Positionen mehr
Profil
Heather A.
Ellerkamp, CPA, aged 40 yrs, joined AutoImmune in February 1994.
Ms. Ellerkamp has been Director of Finance and Treasurer of AutoImmune since June 1997, and from February 1994 to June 1997, she held various financial positions with AutoImmune, including controller.
Ms. Ellerkamp received her B.A.
degree in Management Science from the University of California, San Diego and her M.B.A.
from the University of Michigan.
Effective November 19, 1999, Ms. Ellerkamp ceased being a full time employee of AutoImmune and is currently working in the same capacity on a part-time basis.
Ehemalige bekannte Positionen von Heather A. Ellerkamp
Unternehmen | Position | Ende |
---|---|---|
AutoImmune, Inc.
![]() AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology AutoImmune, Inc. develop products to treat autoimmune and other cell-mediated inflammatory conditions. Its products are based on a biological mechanism known as oral tolerance, which provides tissue specific immunosuppression without toxicity or significant side effects. The company was founded in September 1988 and is headquartered in Pasadena, CA. | Finanzdirektor/CFO | 18.08.2005 |
Ausbildung von Heather A. Ellerkamp
University of California San Diego | Undergraduate Degree |
University of Michigan | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
AutoImmune, Inc.
![]() AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology AutoImmune, Inc. develop products to treat autoimmune and other cell-mediated inflammatory conditions. Its products are based on a biological mechanism known as oral tolerance, which provides tissue specific immunosuppression without toxicity or significant side effects. The company was founded in September 1988 and is headquartered in Pasadena, CA. | Health Technology |